InsidersTradesSigma
Follow the Biora Therapeutics, INC. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Biora Therapeutics, INC. has recorded 50 public disclosures. Market capitalisation: €1,096.4bn. The latest transaction was filed on 16 August 2024 (Retenue fiscale). Among the most active insiders: NEUMANN CLARKE. All data is openly available.
50
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
€4,470
10 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Biora Therapeutics, INC. Strong Buy (bullish), based on 42 analysts. Average price target: US$1,491.95.
29Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,784 of 28,798 companies
71.3
score / 100
Value64
Quality79
FCF yld1.2%
Earn yld6.4%
EV/EBITDA8.1x
ROE67%
Gross mgn40%
Net mgn23%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 August 2024
Declarations50 total
26,629 shares@ US$0.6711.9% of flowCommon StockSEC:0000950170-24-098050:0
27,830 shares@ US$0.6710.8% of flowCommon StockSEC:0000950170-24-098046:0
70,883 shares@ US$0.679.3% of flowCommon StockSEC:0000950170-24-098048:0
12,500 shares0Common StockSEC:0000950170-24-069926:0
12,500 shares0Common StockSEC:0000950170-24-069929:0
12,500 shares0Common StockSEC:0000950170-24-069928:0
12,500 shares0Common StockSEC:0000950170-24-069927:0
819,000 shares0Common StockSEC:0000950170-24-015858:0
230,000 shares0Common StockSEC:0000950170-24-015859:0
325,000 shares0Common StockSEC:0000950170-24-015862:0
9,235,281 sharesCommon StockSEC:0000899243-23-019263:0
36,183 shares@ US$3.1476.3% of flowCommon StockSEC:0000950170-23-043230:0
117,881 shares@ US$3.1473.3% of flowCommon StockSEC:0000950170-23-043221:0
40,022 shares@ US$3.1473.5% of flowCommon StockSEC:0000950170-23-043225:0
12,500 shares0Common StockSEC:0000950170-23-028594:0
12,500 shares0Common StockSEC:0000950170-23-028596:0
12,500 shares0Common StockSEC:0000950170-23-028595:0
12,500 shares0Common StockSEC:0000950170-23-028599:0
11,249 shares@ US$3.357.5% of flowCommon StockSEC:0000950170-23-022770:0
2,368 shares@ US$3.355.3% of flowCommon StockSEC:0000950170-23-022772:0
2,807 shares@ US$3.355.5% of flowCommon StockSEC:0000950170-23-022773:0
57,950 shares0Common StockSEC:0000899243-23-009036:0
155,550 shares0Common StockSEC:0000899243-23-009035:0
62,225 shares0Common StockSEC:0000899243-23-009032:0
269 shares@ US$3.460.6% of flowCommon StockSEC:0000899243-23-005465:0
25 of 50 declarations
About Biora Therapeutics, INC.
Biora Therapeutics, INC. is a company in the health and pharmaceutical sector focused on developing innovative therapeutic solutions. It is listed on NASDAQ under the symbol XNAS.